Scientists say new Chinese vaccine may be safe after early stage trials


An early stage trial of a Chinese coronavirus vaccine published in The Lancet medical journal found that it could be a safe and effective method of inoculation to prevent contraction of COVID-19. 

Those who were administered the vaccine rendered a moderate immune response to the virus, which peaked 28 days after inoculation.

The study was conducted at several laboratories and included 108 participants. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.